Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study
- PMID: 26238717
- PMCID: PMC4523916
- DOI: 10.1186/s12882-015-0132-3
Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study
Abstract
Background: Vascular calcification is a common complication associated with chronic kidney disease and the major cause of cardiovascular disease in patients with end-stage renal disease. The vascular calcification risk burden is still unknown in China. This study aims to investigate the prevalence of vascular calcification and assess the predictive value of vascular calcification in patients with stage 5 chronic kidney disease on dialysis in China.
Methods/design: This is a national, multicenter, non-interventional, prospective cohort study planning to recruit 1520 patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis for at least 6 months in 24 dialysis centers in China. All the patients provided written informed consents before participating in this study. It will include a baseline visit and 24 months follow-up period with 4 other visits at 6-month intervals. Vascular calcification images will be obtained to determine the prevalence of vascular calcification, coronary artery calcification, abdominal aortic calcification and cardiac valve calcification. Association between vascular calcification and all-cause and cardiovascular disease mortality and non-fatal cardiovascular events will be assessed. Disease management, as assessed by serum level of calcium, phosphorus and intact parathyroid hormone and its impact on vascular calcification, will also be surveyed.
Discussion: The new results gained from this study will supplement limited current available data and provide better clinical decisions in Chinese patients with chronic kidney disease on dialysis.
Similar articles
-
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909. JAMA Netw Open. 2023. PMID: 37126347 Free PMC article.
-
Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?J Assoc Physicians India. 2012 Feb;60:102-5. J Assoc Physicians India. 2012. PMID: 22715556
-
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.Curr Med Res Opin. 2018 Aug;34(8):1491-1500. doi: 10.1080/03007995.2018.1467886. Epub 2018 May 3. Curr Med Res Opin. 2018. PMID: 29672176
-
Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.J Ren Nutr. 2006 Apr;16(2):100-18. doi: 10.1053/j.jrn.2006.01.006. J Ren Nutr. 2006. PMID: 16567266 Review.
-
[Cinacalcet therapy and cardiovascular risk in hemodialysis patients].Postepy Hig Med Dosw (Online). 2012 Oct 22;66:722-9. doi: 10.5604/17322693.1015034. Postepy Hig Med Dosw (Online). 2012. PMID: 23175326 Review. Polish.
Cited by
-
GDF10 is a negative regulator of vascular calcification.J Biol Chem. 2024 Nov;300(11):107805. doi: 10.1016/j.jbc.2024.107805. Epub 2024 Sep 21. J Biol Chem. 2024. PMID: 39307303 Free PMC article.
-
Osteocalcin and Abdominal Aortic Calcification in Hemodialysis Patients: An Observational Cross-Sectional Study.Front Endocrinol (Lausanne). 2021 Mar 19;12:620350. doi: 10.3389/fendo.2021.620350. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815281 Free PMC article.
-
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909. JAMA Netw Open. 2023. PMID: 37126347 Free PMC article.
-
Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.PLoS One. 2017 Jan 3;12(1):e0168537. doi: 10.1371/journal.pone.0168537. eCollection 2017. PLoS One. 2017. PMID: 28045985 Free PMC article.
-
Sixty-Two-Year-Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary Hyperparathyroidism.JBMR Plus. 2018 Mar 30;2(4):240-245. doi: 10.1002/jbm4.10038. eCollection 2018 Jul. JBMR Plus. 2018. PMID: 30283905 Free PMC article.
References
-
- Yue X, Binyan S. Kun Zhao. Epidemiology features of end-stage renal disease and the application, cost and payment of dialysis care in China. Chin J Health Pol. 2011;4:29–33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical